DistantNews
Support us
SeoulTech Startup Center Pledges Full Support to Integration and Colosseum After Unicorn Bridge Selection

SeoulTech Startup Center Pledges Full Support to Integration and Colosseum After Unicorn Bridge Selection

From Dong-A Ilbo · () Korean

Translated from Korean and summarized by DistantNews. Read the original for the full story.

At a glance

In-depth Named sources New plan
  • Integration and Colosseum, startups supported by Seoul National University of Science and Technology, were selected for the Ministry of SMEs and Startups’ 2026 Unicorn Bridge program.
  • Integration operates traditional medicine commerce, brands and clinic-management software, while Colosseum provides logistics technology and supply-chain services.
  • Both companies developed through the university’s AWS-linked global corporate collaboration program, which supported data infrastructure, cloud architecture and overseas validation.

Two startups linked to Seoul National University of Science and Technology’s startup center have entered South Korea’s first Unicorn Bridge program, which selected only 50 companies nationwide. The startups are Integration, a traditional medicine platform, and Colosseum Corporation, a global supply-chain management company.

The program, launched by the Ministry of SMEs and Startups in 2026, targets deep-tech companies with proven innovation and growth potential. It aims to help them develop into globally competitive unicorns valued at more than 1 trillion won. Selected companies can receive up to 1.6 billion won in government funding over two years, along with special guarantees of up to 20 billion won from the Korea Technology Finance Corporation.

There is still no Korean company that has turned traditional medicine into a popular brand and taken it global, like Tsumura in Japan, Tong Ren Tang in China or Himalaya in India.

— Integration representativeThe representative explained why the traditional medicine platform was selected for the Unicorn Bridge program.

Integration, founded by CEO Jung Hee-beom in 2019, began with Medistream, a community for Korean medicine doctors. It has since expanded into commerce for Korean medicine clinics, brands including Soo, Linda Diet and Acurex, and Upstream, a clinic-management solution. The company says it generated 56.3 billion won in revenue in 2025 and raised 27.5 billion won in December in a round led by Altos Ventures. It is receiving 600 million won through Unicorn Bridge to explore overseas markets.

We could start investing in data infrastructure without postponing it because we received support in the form of credits.

— Integration representativeThe representative described how AWS credits helped the company build its data-analysis environment.

Colosseum, founded by CEO Park Jin-soo in 2019, has grown from a logistics technology company into a global supply-chain operating system and service provider. It operates 49 domestic hubs and more than 60 logistics centers in countries including the United States, Japan and Taiwan, supporting deliveries to about 249 countries. Its Colo AI fulfillment software and fulfillment-director organization form the core of its model. The company says cumulative revenue surpassed 200 billion won in the first quarter of 2026, with more than 700 customers and 9 million shipments handled.

Both companies previously took part in the startup center’s AWS collaboration track. Integration used AWS credits to build its data-analysis environment, while Colosseum refined its cloud infrastructure, service architecture, pricing and sales strategy. Colosseum also tested Colo AI with AWS Japan and Daiwa Japan, helping support its expansion into Japan.

The close connection between our actual logistics business and technology development is our strength.

— Colosseum representativeThe representative identified the company’s main competitive advantage.
About this summary

Originally published by Dong-A Ilbo in Korean. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.